High Protein, Energy Dense Nutritional Supplement
OtherReady to drink oral supplement
NCT Number: NCT04259437
The purpose of this study is to evaluate the GI tolerance, palatability and compliance to a high protein energy-dense oral nutrition supplement in adult patients with or at risk of malnutrition.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
North Coast Medical Ltd, Newquay Health Centre, Newquay, Cornwall, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ready to drink oral supplement
Time frame: Day 1 to Day 7
Subject completed Bristol Stool Type questionnaire; Stool is classified into 7 groups (Types 1-7) with Type 3-4 as ideal stools.
Time frame: Day 1 to Day 7
Subject completed 6, Likert Scale questions; 4 scaled in the negative direction; 2 scaled from Far Too to Not at all Enough
Time frame: Day 1 to Day 7
Subject completed daily intake questionnaire including amount of Bottle 1 and Bottle 2 consumed
Time frame: Day 7
Subject completed 6, Likert Scale questions; 4 scaled in the negative direction; 2 scaled from Far Too to Not at all Enough for additional flavors
Time frame: Baseline to Day 7
Subject reported medication usage
Time frame: Baseline and Day 7
For BMI Calculation
Abbott Nutrition
Industry
A Study to Evaluate the Gastrointestinal Tolerance and Acceptability of a High Energy, High Protein Low Volume Oral Nutritional Supplement in Adult Patients With or at Risk of Malnutrition
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04915937
Gastro-Intestinal Tolerance
Phoenix, Arizona, United States
View Trial DetailsNCT03967132
Gastro-Intestinal Tolerance
Tucson, Arizona, United States
View Trial DetailsNCT03293706
Gastro-Intestinal Tolerance
Toronto, Ontario, Canada
View Trial DetailsNCT01782456
Gastro-Intestinal Tolerance
Cincinnati, Ohio, United States
View Trial Details